Project Overview
Lung cancer accounts for 5.9% of all cancersand 8.1% of cancer-related deaths in India, with smoking linked to nearly 80% of cases. Over 70% of patients are diagnosed at advanced stages, when treatment is less effective. The Indian market opportunity exceeds $100 million, yet there are currently no POC solutions. Rapid, AI-driven tests for triage and monitoring represent a clear first-mover advantage.
